Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vastera logo — Pioneering innovative treatments for cardiovascular and canc...

Vastera

Pioneering innovative treatments for cardiovascular and cancer diseases through novel redox signaling pathways

Founded 2018 Series B Total: $23.50B Biotechnology, Health Care +1

General Information

Company Name Vastera
Founded Year 2018
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Vastera. To contact Vastera, visit vasthera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Vastera

Vastera is a biotech startup pioneering innovative treatments for cardiovascular and cancer diseases through novel redox signaling pathways. Founded by SangWon Kang, a professor at Ewha Womans University, in 2018, the company is focused on creating "first-in-class" therapies in these medical areas, leveraging research on redox signaling in blood vessels and cancer. The company's mostrecent funding round was a KRW18.00B Series B investment on 02 March 2022, with participation from a diverse group of investors including SJ Investment Partners, Partners Investment, Daesung Private Equity, UTC 2019 BioVentureFund, ID Ventures, Medytox Venture Investment, Shinan Venture Investment, and Medici Investment. Vastera's focus on biotechnology and healthcare positions it at the intersection of cutting-edge medical research and high-potential market opportunities. With a strong founding team and impressive investor backing, the company is poised to make meaningful advancements in the treatment of cardiovascular and cancer diseases utilizing innovative approaches to redox signaling.

Taxonomy: Biotech, Cardiovascular Diseases, Cancer Treatment, Redox Signaling Pathways, Innovative Therapies, Medical Research, Ewha Womans University, Biomedical Innovation, Patent Development, Healthcare Innovation, Biomedical Startups, Medical Technology, First-in-Class Therapies

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B KRW18.00B 8
SJ Investment Partners Partners Investment Daesung Private Equity
SJ Investment Partners, Partners Investment +6
02 Mar 2022
Series A KRW5.50B -
12 Nov 2020
Venture Round Undisclosed 1
Premier Partners
Premier Partners
01 Nov 2020

Vastera Alternatives & Competitors

View All Alternatives
Vastera vs
MAX BioPharma, Inc.
MAX BioPharma, Inc. United States

Pioneering new treatments for severe and life-threatening illnesses through innovative small molecul...

12 employees
Biopharma, Biotechnology
Vastera vs
Khloris Biosciences
Khloris Biosciences

Pioneering medical treatment using advanced stem cell technology to address critical cardiovascular...

Venture round
Biotechnology, Life Sciences
Vastera vs
SCG Cell Therapy
SCG Cell Therapy Singapore

Leading the Next Wave of Biotech Breakthroughs

Series C
24 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Vastera

Pioneering innovative treatments for cardiovascular and cancer diseases through novel redox signaling pathways
Vastera was founded in 2018.
Vastera operates in Biotechnology, Health Care and Life Sciences. Its work centres on Biotech, Cardiovascular Diseases, Cancer Treatment and Redox Signaling Pathways.
Vastera has completed 3 funding rounds, raising a total of $23.50B. The latest funding stage is Series B.
Top alternatives and competitors to Vastera include MAX BioPharma, Inc., Khloris Biosciences, SCG Cell Therapy, Genecure, EraCal Therapeutics . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vastera and MAX BioPharma, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vastera, https://bouncewatch.com/company/vastera, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes